Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pratima Kumari
The FDA-approved Gold Drug Auranofin Inhibits Novel Coronavirus (SARS-COV-2) Replication and Attenuates Inflammation in Human Cells
Related publications
FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro
Insights Into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
Pathogens
Immunology
Molecular Biology
Allergy
Microbiology
Microbiology
Infectious Diseases
The Emergence of a Novel Coronavirus (SARS-CoV-2), Their Biology and Therapeutic Options
Journal of Clinical Microbiology
Microbiology
Novel Coronavirus (SARS-CoV-2) Infection in a Renal Transplant Recipient: Case Report
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
Comparative Genomic Analysis Revealed Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13
Genome-Wide Data Inferring the Evolution and Population Demography of the Novel Pneumonia Coronavirus (SARS-CoV-2)
Deducing the N- And O- Glycosylation Profile of the Spike Protein of Novel Coronavirus SARS-CoV-2
RT‐LAMP for Rapid Diagnosis of Coronavirus SARS‐CoV‐2
Microbial Biotechnology
Applied Microbiology
Biotechnology
Biochemistry
Bioengineering